GlassScriptPhysician profile
Lisa Lewis
NPI 1285648725
$1,765.19
in general payments reported to CMS, 2019-2025
20 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $310 · 2022: $280 · 2023: $489 · 2024: $316 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $982 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.18 |
| Education | $193.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $501.99 | 2023-2025 | Veozah |
| Abbvie INC. | $256.97 | 2021-2023 | |
| Shield Therapeutics INC | $181.47 | 2023-2024 | Accrufer |
| Aspira Women'S Health INC | $123.91 | 2021-2023 | Ova1 |
| Exeltis, USA INC. | $98.69 | 2022-2025 | Slynd |
| Hologic Sales and Service, LLC | $63.38 | 2021-2025 | Aptima |
| Pfizer INC. | $60.46 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $57.06 | 2023-2024 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $56.08 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $51.98 | 2021 | |
| Millicent US INC | $45.43 | 2025 | Femlyv |
| Coopersurgical, INC. | $43.32 | 2023 | Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Merck Sharp & Dohme LLC | $38.97 | 2022-2024 | Gardasil 9, Gardasil |
| Organon LLC | $37.84 | 2024-2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $35.03 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $31.26 | 2022-2023 | |
| Daiichi Sankyo INC. | $29.29 | 2024 | Injectafer |
| Evofem Biosciences, INC. | $23.52 | 2021 | |
| Agile Therapeutics, INC. | $16.61 | 2021 | |
| Scynexis, INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.